Log in

NASDAQ:BRKR - Bruker Stock Price, Forecast & News

$50.42
+0.47 (+0.94 %)
(As of 12/8/2019 05:08 AM ET)
Today's Range
$50.30
Now: $50.42
$50.76
50-Day Range
$43.23
MA: $47.96
$51.33
52-Week Range
$26.10
Now: $50.42
$52.23
Volume404,046 shs
Average Volume545,174 shs
Market Capitalization$7.76 billion
P/E Ratio36.01
Dividend Yield0.32%
Beta1.43
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Current SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.90 billion
Cash Flow$1.84 per share
Book Value$5.78 per share

Profitability

Net Income$179.70 million

Miscellaneous

Employees6,870
Market Cap$7.76 billion
Next Earnings Date2/10/2020 (Estimated)
OptionableOptionable

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.


Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Thursday, November 14th. Investors of record on Monday, December 2nd will be given a dividend of $0.04 per share on Friday, December 20th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Friday, November 29th. View Bruker's Dividend History.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) announced its earnings results on Thursday, October, 31st. The medical research company reported $0.43 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.38 by $0.05. The medical research company earned $521.10 million during the quarter, compared to analysts' expectations of $493.52 million. Bruker had a net margin of 10.20% and a return on equity of 28.02%. The business's revenue was up 11.7% on a year-over-year basis. During the same period last year, the firm posted $0.37 EPS. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Monday, February 10th 2020. View Earnings Estimates for Bruker.

What price target have analysts set for BRKR?

11 brokers have issued 12-month price objectives for Bruker's shares. Their forecasts range from $43.00 to $58.00. On average, they anticipate Bruker's share price to reach $51.40 in the next twelve months. This suggests a possible upside of 1.9% from the stock's current price. View Analyst Price Targets for Bruker.

What is the consensus analysts' recommendation for Bruker?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.

Has Bruker been receiving favorable news coverage?

News stories about BRKR stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bruker earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned news stories about the medical research company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Bruker.

Are investors shorting Bruker?

Bruker saw a drop in short interest in November. As of November 15th, there was short interest totalling 2,650,000 shares, a drop of 9.2% from the October 31st total of 2,920,000 shares. Based on an average daily trading volume, of 664,200 shares, the short-interest ratio is presently 4.0 days. Currently, 2.6% of the shares of the company are short sold. View Bruker's Current Options Chain.

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include Biogen (BIIB), Netflix (NFLX), Alibaba Group (BABA), Costco Wholesale (COST), Intel (INTC), salesforce.com (CRM), Nike (NKE), Thermo Fisher Scientific (TMO), Illumina (ILMN) and Lululemon Athletica (LULU).

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
  • Dr. Falko Busse, Exec. Officer (Age 52)

Who are Bruker's major shareholders?

Bruker's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (0.92%), First Trust Advisors LP (0.40%), Russell Investments Group Ltd. (0.34%), Boston Trust Walden Corp (0.33%), Eagle Asset Management Inc. (0.23%) and Great Lakes Advisors LLC (0.23%). Company insiders that own Bruker stock include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Institutional Ownership Trends for Bruker.

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, State Street Corp, Russell Investments Group Ltd., Fisher Asset Management LLC, Boston Trust Walden Corp, Parametric Portfolio Associates LLC, Point72 Asset Management L.P. and Eagle Asset Management Inc.. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Insider Buying and Selling for Bruker.

Which institutional investors are buying Bruker stock?

BRKR stock was acquired by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Man Group plc, Sector Gamma AS, California Public Employees Retirement System, GW&K Investment Management LLC, Mackay Shields LLC, Virginia Retirement Systems ET AL and Ferguson Wellman Capital Management Inc.. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $50.42.

How big of a company is Bruker?

Bruker has a market capitalization of $7.76 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.View Additional Information About Bruker.

What is Bruker's official website?

The official website for Bruker is http://www.bruker.com/.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (NASDAQ BRKR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  591 (Vote Outperform)
Underperform Votes:  638 (Vote Underperform)
Total Votes:  1,229
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Featured Article: Accumulation/Distribution

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel